Evidence map›Paper›PMID 24132210›Full record

ArticleKidney international2014

Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats.

Hewang Lee, Yoshifusa Abe, Icksoo Lee, Shashi Shrivastav, Annabelle P Crusan, Maik Hüttemann, Ulrich Hopfer, Robin A Felder, Laureano D Asico, Ines Armando and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Kidney international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Annual reports on hypertension research 2020.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  11. Review
  12. Article
  13. Dopamine DHypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  14. Renal metabolism and hypertension.Nature communications · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Hewang Lee1] Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA [2] Kidney Disease Section, Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Yoshifusa AbeKidney Disease Section, Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Icksoo LeeCollege of Medicine, Dankook University, Cheonan-si, Chungcheongnam-do, Korea.
Shashi ShrivastavKidney Disease Section, Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Annabelle P CrusanDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Maik HüttemannCenter for Molecular Medicine and Genetics and Cardiovascular Research Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
Ulrich HopferDepartment of Physiology and Biophysics, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA.
Robin A FelderDepartment of Pathology, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA.
Laureano D AsicoDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Ines ArmandoDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pedro A JoseDivision of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Jeffrey B KoppKidney Disease Section, Kidney Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
University of Maryland, Baltimore · USNational Institutes of Health · USDankook University · KRUniversity of Virginia · USUniversity School · USWayne State University · US

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAREY, ROBERT MUNSON · 2004 to 2020
$31.8M
Renal Vascular Oxidative Stress in HypertensionP01HL068686 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A., SANDBERG, KATHRYN L · 2001 to 2017
$28.8M
Focal Segmental Glomerulosclerosis: Genetics & MechanismsZIADK043308 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOPP, JEFFREY BURNETT · 2009 to 2024
$15.7M
RENAL DOPAMINE-1 RECEPTOR DEFECT IN HYPERTENSIONR01DK039308 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 1987 to 2020
$7.4M
Renal Dopamine Receptor & RegulationR37HL023081 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI JOSE, PEDRO A. · 2007 to 2016
$4.3M
GRK4 & Development of Salt SensitivityR01HL092196 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ARMANDO, INES, JOSE, PEDRO A. · 2008 to 2017
$3.6M
RENAL DOPAMINE RECEPTOR REGULATION AND FUNCTIONR01HL023081 · NHLBI · GEORGETOWN UNIVERSITY · PI JOSE, PEDRO A. · 1985 to 2006
$2.4M
Role of Dopamine D2 Receptor in Renal Inflammation and InjuryR01DK090918 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ARMANDO, INES · 2011 to 2015
$1.7M
FOCAL SEGMENTAL GLOMERULOSCLEROSIS--PATHOGENESIS AND TREATMENTZ01DK043308 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOPP, JEFFREY BURNETT · 1997 to 2008
$1.0M
Intramural NIH HHS Z01 DK043308NHLBI NIH HHS P01 HL068686NHLBI NIH HHS P01HL068686NHLBI NIH HHS P01 HL074940NHLBI NIH HHS P01HL074940NHLBI NIH HHS R01 HL023081NHLBI NIH HHS R01 HL092196NHLBI NIH HHS R01HL092196NHLBI NIH HHS R37 HL023081NHLBI NIH HHS R37HL023081NIDDK NIH HHS DK090918NIDDK NIH HHS R01 DK039308NIDDK NIH HHS R01DK039308NIDDK NIH HHS R01 DK090918NIDDK NIH HHS Z01DK043308
6 · The paper itself

Abstract

Renal proximal tubule cells from spontaneously hypertensive rats (SHR), compared with normotensive Wistar-Kyoto rats (WKY), have increased oxidative stress. The contribution of mitochondrial oxidative phosphorylation to the subsequent hypertensive phenotype remains unclear. We found that renal proximal tubule cells from SHR, relative to WKY, had significantly higher basal oxygen consumption rates, adenosine triphosphate synthesis-linked oxygen consumption rates, and maximum and reserve respiration. These bioenergetic parameters indicated increased mitochondrial function in renal proximal tubule cells from SHR compared with WKY. Pyruvate dehydrogenase complex activity was consistently higher in both renal proximal tubule cells and cortical homogenates from SHR than those from WKY. Treatment for 6 days with dichloroacetate, an inhibitor of pyruvate dehydrogenase kinase, significantly increased renal pyruvate dehydrogenase complex activity and systolic blood pressure in 3-week-old WKY and SHR. Therefore, mitochondrial oxidative phosphorylation is higher in renal proximal tubule cells from SHR compared with WKY. Thus, the pyruvate dehydrogenase complex is a determinant of increased mitochondrial metabolism that could be a causal contributor to the hypertension in SHR.

Indexed as

Adenosine TriphosphateAnimalsBlood PressureCells, CulturedGlycolysisHypertensionKidney Tubules, ProximalMaleMitochondriaPyruvate Dehydrogenase ComplexRats, Inbred SHRRats, Inbred WKYAdenosine TriphosphatePyruvate Dehydrogenase Complex

Identifiers

PMID24132210
PMCPMC3943540
OpenAlexW2040012879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.